How to Inject BPC-157: SubQ, IM, and Dosing Basics

Built by medical professionals, gym rats, and experienced biohackers

Quick Answer

BPC-157 is most commonly injected subcutaneously (under the skin) or intramuscularly (into muscle tissue) using a small insulin syringe. Most research protocols use a 27 to 31 gauge needle and doses in the range of 200 to 500 mcg per injection . Injection is the preferred delivery method because peptides like BPC-157 break down in the digestive tract before reaching the bloodstream.

What Is BPC-157 and Why Does Injection Method Matter?

BPC-157 (Body Protection Compound-157) is a synthetic peptide made up of 15 amino acids. It is derived from a protein sequence found in human gastric juice . Like most peptides, it cannot survive oral digestion intact. Stomach acid and digestive enzymes break down the amino acid chain before it can be absorbed into the bloodstream in useful amounts.

That is why researchers who study BPC-157 use injectable delivery. Subcutaneous and intramuscular injection allow the peptide to enter systemic circulation relatively intact. Animal studies have documented effects on angiogenesis (new blood vessel formation), collagen synthesis, and tissue repair signaling pathways . These findings drive interest in BPC-157 among people exploring recovery from physical training and injury.

Choosing the right injection method and technique matters both for safety and consistency. The steps below reflect what researchers and experienced self-experimenters use in practice.

Subcutaneous vs. Intramuscular Injection

Two injection methods are common with BPC-157:

Subcutaneous (SubQ)
- The needle goes just beneath the skin into the fatty tissue layer
- Common sites: lower abdomen, outer thigh, lower back (love handle area)
- Easiest method for most people to perform on themselves
- Slower absorption compared to intramuscular

Intramuscular (IM)
- The needle goes into muscle tissue
- Common sites: outer thigh (vastus lateralis), deltoid, glutes
- Some researchers use IM when targeting a specific muscle or joint region nearby
- Faster absorption than SubQ in general

Most people in BPC-157 research communities default to SubQ and switch to IM only when addressing a localized area such as a shoulder or knee. No human clinical data has definitively established one method as superior over the other .

Step-by-Step: How to Reconstitute and Inject BPC-157

Supplies needed:
- BPC-157 peptide vial (lyophilized powder)
- Bacteriostatic water (BAC water) for reconstitution
- Insulin syringes, 27 to 31 gauge (0.5 mL or 1 mL capacity)
- Alcohol swabs
- Sharps disposal container

Reconstitution

Wipe the rubber stopper on both the peptide vial and the BAC water vial with a fresh alcohol swab.
Draw the desired amount of BAC water into a clean syringe.
Insert the needle into the peptide vial at an angle and release the water slowly along the glass wall. Do not aim the stream directly at the powder.
Swirl gently. Never shake the vial.
Most researchers use 1 to 2 mL of BAC water per vial . Your concentration per unit depends on this ratio.

A common example: a 5 mg vial reconstituted with 2 mL BAC water gives 2500 mcg per mL, or 250 mcg per 0.1 mL drawn.

Injection steps

Wash your hands thoroughly with soap and water.
Swab the injection site with an alcohol swab and allow it to air dry for 10 to 15 seconds.
Pinch a small fold of skin at the site (for SubQ) or hold the skin taut (for IM).
Insert the needle at a 45-degree angle for SubQ or 90 degrees for IM.
Release the skin fold if applicable.
Press the plunger slowly and steadily.
Withdraw the needle and apply light pressure with a clean swab.
Dispose of the syringe in a sharps container immediately. Never recap or reuse a needle.

Never inject into an area showing redness, swelling, warmth, or signs of infection.

Dosing Ranges Used in Research Protocols

Typical self-research dosing for BPC-157 falls in the range of 200 to 500 mcg per day , often given as one or two injections. Some protocols go as high as 1000 mcg per day , though no established human clinical dose exists since BPC-157 is not FDA-approved for general human use.

Animal studies have used doses in the 2 to 10 mcg per kg body weight range . Scaled to a 180-pound human, that approximates the lower end of the ranges above. Interspecies dose scaling is not straightforward, and published human pharmacokinetic data for BPC-157 is not publicly available at this time.

Keeping accurate records of what you inject, when you inject it, and where you inject it is one of the most valuable habits in any peptide research protocol. Tools like DoseVault are built specifically for tracking peptide cycles, injection sites, and timing so you can spot patterns and stay consistent across a protocol.

Rotating Injection Sites

Injecting the same spot repeatedly causes localized irritation, bruising, and can lead to subcutaneous tissue changes over time. Site rotation is a standard practice in any injectable protocol.

Suggested rotation for SubQ:
- Left abdomen, right abdomen (alternating daily)
- Left outer thigh, right outer thigh
- Left lower back, right lower back

Avoid returning to the same site within two to three days. If a site shows redness, tenderness, or a firm lump, skip it until it clears. These signs can indicate minor inflammation or a small hematoma, both of which resolve with rest.

Storage and Handling

Lyophilized BPC-157 is relatively stable at room temperature for short periods, but refrigeration at 2 to 8 degrees Celsius is the standard for any peptide stored beyond a few days . Once a vial is reconstituted, store it in the refrigerator and use it within 28 to 30 days . Keep vials away from light and heat, and never freeze a reconstituted peptide solution.

Write the reconstitution date on each vial label. This removes guesswork about freshness and helps you maintain consistent tracking across your protocol.

Frequently Asked Questions

What needle gauge should I use for BPC-157 injections?
Most researchers use 27 to 31 gauge needles. Higher gauge numbers mean thinner needles with less discomfort. A 29 or 31 gauge insulin syringe works well for SubQ injections into the abdomen or thigh. For IM injections into larger muscle groups, a 25 to 27 gauge needle may be preferred for adequate depth penetration.

How often should BPC-157 be injected?
Research protocols typically use one or two injections per day . Some people use a single morning injection while others split the dose morning and evening. No optimal frequency has been established in human clinical trials.

Can BPC-157 be injected directly into a joint?
Intra-articular injection is a separate clinical technique requiring sterile conditions and precise anatomical knowledge. It is not appropriate outside of a clinical setting. Most researchers use SubQ or IM injection near a joint rather than directly into the joint space.

Does injection location affect how BPC-157 works?
Some researchers theorize that injecting near the area of interest may concentrate local delivery. Animal models show systemic absorption through SubQ injection as well . No definitive human data exists comparing local versus distal injection outcomes for BPC-157.

Disclaimer: This page is for educational purposes only. BPC-157 is not approved by the FDA for human use. Nothing on this page constitutes medical advice or a recommendation to use any compound. Always consult a licensed healthcare provider before beginning any injectable protocol or using research peptides.

Built by medical professionals, gym rats, and experienced biohackers

Running a BPC-157 protocol and want to stay organized? DoseVault lets you log every injection, track sites, record doses, and monitor your full peptide cycle from one clean dashboard. Built for people who take their research seriously.